<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>27(6)</volume><submitter>Rodolico A</submitter><funding>The authors received no specific funding for this work.</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Schizophrenia treatment with antipsychotics often results in side effects that impact adherence and quality of life. Managing these effects remains challenging, as it requires balancing efficacy and tolerability. The Schizophrenia Technological Evaluation of Patient Side Effects (STEP-SE) app aims to aid side effects monitoring and management through shared decision-making (SDM).&lt;h4>Aim&lt;/h4>This study aimed to evaluate the usability of the STEP-SE app for patients and clinicians in managing antipsychotic side effects.&lt;h4>Methods&lt;/h4>Sixteen stable outpatients and 14 psychiatrists participated in semi-structured interviews after using the STEP-SE app. Questions explored ease of use, information clarity, user needs fulfilment, patient-clinician collaboration, treatment adh</pubmed_abstract><journal>Health expectations : an international journal of public participation in health care and health policy</journal><pagination>e70019</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11528129</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Developing STEP-SE: A Qualitative Usability Study of a Novel Patient-Reported Outcomes Tool for Managing Side Effects in Shared Decision-Making for Schizophrenia Spectrum Disorder Care.</pubmed_title><pmcid>PMC11528129</pmcid><pubmed_authors>Muller K</pubmed_authors><pubmed_authors>Mineo L</pubmed_authors><pubmed_authors>Caponnetto P</pubmed_authors><pubmed_authors>Leotta G</pubmed_authors><pubmed_authors>Di Francesco A</pubmed_authors><pubmed_authors>Concerto C</pubmed_authors><pubmed_authors>Bighelli I</pubmed_authors><pubmed_authors>Rodolico A</pubmed_authors><pubmed_authors>Quattropani MC</pubmed_authors><pubmed_authors>Cutrufelli P</pubmed_authors><pubmed_authors>Conti D</pubmed_authors><pubmed_authors>Messina A</pubmed_authors><pubmed_authors>Furnari R</pubmed_authors><pubmed_authors>Petralia A</pubmed_authors><pubmed_authors>Siafis S</pubmed_authors><pubmed_authors>Signorelli MS</pubmed_authors><pubmed_authors>Leucht S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Developing STEP-SE: A Qualitative Usability Study of a Novel Patient-Reported Outcomes Tool for Managing Side Effects in Shared Decision-Making for Schizophrenia Spectrum Disorder Care.</name><description>&lt;h4>Background&lt;/h4>Schizophrenia treatment with antipsychotics often results in side effects that impact adherence and quality of life. Managing these effects remains challenging, as it requires balancing efficacy and tolerability. The Schizophrenia Technological Evaluation of Patient Side Effects (STEP-SE) app aims to aid side effects monitoring and management through shared decision-making (SDM).&lt;h4>Aim&lt;/h4>This study aimed to evaluate the usability of the STEP-SE app for patients and clinicians in managing antipsychotic side effects.&lt;h4>Methods&lt;/h4>Sixteen stable outpatients and 14 psychiatrists participated in semi-structured interviews after using the STEP-SE app. Questions explored ease of use, information clarity, user needs fulfilment, patient-clinician collaboration, treatment adh</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2025-04-19T18:11:35.157Z</modification><creation>2025-04-19T18:11:35.157Z</creation></dates><accession>S-EPMC11528129</accession><cross_references><pubmed>39482944</pubmed><doi>10.1111/hex.70019</doi></cross_references></HashMap>